Drug dosing during continuous hemofiltration;Medikamentendosierung bei kontinuierlicher hämofiltration

Intensivmedizin und Notfallmedizin

Volumn 40, Issue 5, 2003, Pages 369-381

  Czock, D ^a   Keller, Frieder ^a   Thalhammer, F ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dose Adjustment; Hemofiltration; Intensive Care; Pharmacodynamics; Pharmacokinetics

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; AMPICILLIN; ANTIINFECTIVE AGENT; AZLOCILLIN; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFPIROME; CEFRADINE; CEFTAZIDIME; CILASTATIN; CIPROFLOXACIN; FLUCLOXACILLIN; FLUCONAZOLE; GANCICLOVIR; GENTAMICIN; IMIPENEM; INDINAVIR; ISEPAMICIN; LEVOFLOXACIN; MEFLOQUINE; MEROPENEM; OXACILLIN; PIPERACILLIN; RITONAVIR; SAQUINAVIR; SULBACTAM; TAZOBACTAM; UNINDEXED DRUG; VANCOMYCIN;

CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DOSE CALCULATION; HALF LIFE TIME; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; MAINTENANCE DRUG DOSE; MICROORGANISM; RELIABILITY; RISK FACTOR; SEPSIS; TREATMENT FAILURE;

EID: 0037490811     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00390-003-406-z     Document Type: Conference Paper

References (17)

1. Andes D, van Ogtrop ML, Peng J, Craig WA (2002) In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother 46(11):3484-3489
2. Bugge JF (2001) Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand 45: 929-934
3. Dettli L (1973) Translation of pharmacokinetics to clinical medicine. J Pharmacokinet Biopharm 1(5):403-418
4. Domenig C, Traunmuller F, Kozek S, Wisser W, Klepetko W, Steininger R, Spiss C, Thalhammer F (2001) Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection. Transplantation 71:744-745
5. Holford NH (1999) Target concentration intervention: beyond Y2K. Br J Clin Pharmacol 48:9-13
6. Keller F, Wagner K, Borner K, Kemmerich B, Lode H, Offermann G, Distler A (1986) Aminoglycoside dosage in hemodialysis patients. J Clin Pharmacol 26:690-695
7. Keller F, Borner K, Schwarz A, Offermann G, Lode H (1987) Therapeutic aminoglycoside monitoring in renal failure patients. Ther Drug Monit 9:148-153
8. Keller F, Bohler J, Czock D, Zellner D, Mertz AK (1999) Individualized drug dosage in patients treated with continuous hemofiltration. Kidney Int Suppl 72:S29-S31
9. Kunin CM (1967) A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels. Ann Intern Med 67:151-158
10. Kunzendorf U, Keller F, Walz G, Haller H, Offermann G, Borner K, Lode H (1989) Multivariate analysis of aminoglycoside levels in hemodialysis patients. Chemotherapy 35:1-6
11. Lohr JW, Willsky GR, Acara MA (1998) Renal drug metabolism. Pharmacol Rev 50:107-141
12. Moore RD, Smith CR, Lietman PS (1984) Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med 77:657-662
13. Moore RD, Lietman PS, Smith CR (1987) Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155:93-99
14. Prins JM, Buller HR, Kuijper EJ, Tange RA, Speelman P (1993) Once versus thrice daily gentamicin in patients with serious infections. Lancet 341:335-339
15. Schmaldienst S, Traunmuller F, Burgmann H, Rosenkranz AR, Thalhammer-Scherrer R, Horl WH, Thalhammer F (2000) Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes. Eur J Clin Pharmacol 56:61-64
16. Thalhammer F, Horl WH (2000) Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy. Clin Pharmacokinet 39:271-279
17. Traunmuller F, Schenk P, Mittermeyer C, Thalhammer-Scherrer R, Ratheiser K, Thalhammer F (2002) Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients. J Antimicrob Chemother 49:129-134